13 results
COVID-19 Infection - Clinical Presentation and Disease Progression for Severe Cases

Via https://doi.org/10.1007/s00134-020-05967-x

#COVID19 #Hospitalization #Disease #Progression #Severe
COVID-19 Infection ... Presentation and Disease ... 020-05967-x #COVID19 ... Progression #Severe #Coronavirus ... #Diagnosis #Management
Multi-System Inflammatory Syndrome in Children (MIS-C) vs. Kawasaki Disease
CDC Case Definition for MIS-C;
 • < 21
Kawasaki Disease ... • Positive COVID ... Comparison #diagnosis #peds ... #pediatrics #COVID19 ... #Coronavirus #MultiSystem
Mount Sinai COVID-19 Anticoagulation Algorithm

Inclusion: All admitted patients with COVID-19
Exclusion: High risk of bleeding as judged
Mount Sinai COVID ... -19 Anticoagulation ... recent bleeding #Anticoagulation ... #SARSCOV2 #Management ... #Coronavirus
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
• Infection: Coronavirus ... Disease 2019 a.k.a ... -2, 2019 Novel Coronavirus ... Cheatsheet #Diagnosis #Management ... Summary #SARSCoV2 #Coronavirus
Behcet's Syndrome - Treatment
Ulcers:
 • Treatment: Topical steroids
 • Prevention: Colchicine
 • Azathioprine for refractory disease
Arthritis:
for refractory disease ... immunosuppressive meds ... immunosuppressive meds ... • +/- Anticoagulation ... Syndrome #Treatment #management
Therapeutic Management of Adults Hospitalized for COVID-19 Based on Disease Severity
Antiviral, Immunomodulator and Anticoagulation Recommendations by
Therapeutic Management ... -19 Based on Disease ... Immunomodulator and Anticoagulation ... Recommendations by Disease ... #Management #anticoagulation
Possible approach to empiric anticoagulation in COVID-19

Is D-dimer above '"1,000-2,000 ng/ml?
Contraindication to anticoagulation?
Check fibrinogen level and/or
approach to empiric anticoagulation ... in COVID-19 ... -> Therapeutic Anticoagulation ... #COVID19 #management ... algorithm #SARSCOV2 #Coronavirus
Possible Approach to Immunosuppression in Severe COVID-19

The diagnosis and treatment of cytokine storm remains unknown and
Immunosuppression in Severe COVID ... iBookCC #empiric #anticoagulation ... #COVID19 #management ... algorithm #SARSCOV2 #Coronavirus
CDC Risk Classification for Asymptomatic Healthcare Personnel Following Exposure to Patients with Coronavirus Disease (COVID-19) or
Patients with Coronavirus ... Disease (COVID- ... Classification #COVID19 ... #Restrictions #Management
Bamlanivimab EUA - High Risk Criteria
 • BMI ≥ 35
 • Chronic kidney disease
 • Diabetes
Chronic kidney disease ... Immunosuppressive disease ... Cardiovascular disease ... EUA #Criteria #covid19 ... #coronavirus #management